Table 3 Clinicopathologic characteristics of patients receiving palliative chemotherapy

Age,

Median: 59 (36-74)

Sex

   Male

12

92.3%

   Female

1

7.7%

ECOG PS

   0-1

11

84.6

   2

2

15.4

Stage

   Stage IV at diagnosis

6

46.2%

   Recurred cancer

7

53.8%

Portal vein thrombosis

   Yes

8

61.5%

   No

5

38.5%

Metastasis

   LN

9

69.2%

   Liver

8

61.5%

   Peritoneal seeding

3

23.1%

   Pancreas

2

15.4%

   lung

1

7.7%

Gastrectomy

   Yes

10

76.9%

   No

3

23.1%

Number of metastatic organ

   1-2

8

61.5%

   > 3

5

38.5%

Chemotherapy

   Up to 1^st line

13

100%

   Up to 2^nd line

7

53.8%

   Up to 3^rd line

1

7.7%

Chemotherapeutic agent

   FP/XP/FOLFOX^†

7

53.8%

   TP^‡

2

15.4%

   TS-1

2

15.4%

   Others (FL^§, FM^¶)

2

15.4%